Innovations in Cytotoxic Drugs Contract Manufacturing: Overcoming Industry Challenges
cytotoxic drugs contract manufacturing The cytotoxic drugs contract manufacturing industry has witnessed rapid growth in recent years, fueled by advancements in pharmaceutical research and the increasing prevalence of cancer. However, this sector also faces unique challenges that require innovative solutions to ensure continued success and progress in the production of cytotoxic drugs. The global Cytotoxic Drugs Contract Manufacturing Market size was valued at US$ 6,285.2 million in 2018, and is expected to exhibit a CAGR of 9.1% over the forecast period (2019-2027). One of the primary challenges in cytotoxic drugs contract manufacturing is the need for specialized equipment and facilities. Manufacturing cytotoxic drugs involves handling potent compounds that pose significant health risks to operators. To address this challenge, contract manufacturing organizations (CMOs) have invested heavily in advanced technologies and infrastructure, including closed s...